FDA Unveils White Paper on AI Medical Device Regulation: Key Insights and Implications
On March 15, 2024, the U.S. Food and Drug Administration (FDA) published a white paper detailing its collaborative efforts to…
Category: AI Policy & Regulation
Understanding the FDA’s Strategy for Regulating AI in Medical Products
On March 15, 2024, the U.S. Food and Drug Administration (FDA) released a significant publication titled “Artificial Intelligence and Medical Products:…
The Evolving Regulatory Framework for AI in U.S. Healthcare: What You Need to Know
Unlike many countries that are implementing cohesive regulations for artificial intelligence (AI), the United States has chosen a more disjointed…
Addressing Bias in Healthcare AI: What Congress is Doing to Protect Patients
As artificial intelligence (AI) continues to integrate into healthcare, federal legislators are evaluating strategies to safeguard patients while encouraging innovation.…
US Lawmakers Review AI Payment and Coverage Policies in Healthcare
U.S. lawmakers are currently examining effective payment and coverage policies for artificial intelligence (AI) within the healthcare sector. According to…